Literature DB >> 15362486

Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.

I Ahmed1, E Adeghate, E Cummings, A K Sharma, J Singh.   

Abstract

This study investigated the beneficial effects and mechanism of action of the juice of Momordica charantia in streptozotocin (STZ)-induced diabetes mellitus in rats. Diabetes mellitus was associated with significant (p < 0.01) time course reductions in body weight, plasma insulin and the number of insulin positive cells per islet and significant (p < 0.01) time course elevation in blood glucose and osmolarity and systolic blood pressure compared to age-matched healthy controls. Oral intake of M. charantia juice by STZ-induced diabetic rats partially reversed all the diabetes-induced effects measured. Daily oral administration of M. charantia juice to STZ-induced diabetic rates significantly (p < 0.01) reduced the Na+- and K+-dependent absorptions of glucose by the brush border membrane vesicles of the jejunum compared to the responses obtained in STZ-induced diabetic rat. Either insulin (100 MM) or the fruit juice lyophilised extract (5 microg x ml(-1)) can stimulate 14C-D-glucose uptake in L6 myotubes. These effects were completely blocked by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. High concentrations (10-200 microg x ml(-1)) of M. charantia juice extract inhibited 14C-D-glucose uptake in L6 myotubes compared to the control response. The effect of M. charantia treatment was also investigated on myelinated fibre abnormalities in the tibial nerve of STZ-induced diabetic and control rats. The results show that diabetes was associated with significant (p < 0.05) reduction in the mean cross-sectional myelinated nerve fibres, axonal area, myelin area and maximal fibre area compared to end controls. Treatment of STZ-induced diabetic rats with M. charantia juice normalised the structural abnormalities of peripheral nerves. The results indicate that M. charantia can exert marked beneficial effects in diabetic rats, and moreover, it can regulate glucose uptake into jejunum membrane brush border vesicles and stimulate glucose uptake into skeletal muscle cells similar to the response obtained with insulin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15362486     DOI: 10.1023/b:mcbi.0000028738.95518.90

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  20 in total

1.  Preparation and properties of brush-border membrane vesicles from human small intestine.

Authors:  S P Shirazi-Beechey; A G Davies; K Tebbutt; J Dyer; A Ellis; C J Taylor; P Fairclough; R B Beechey
Journal:  Gastroenterology       Date:  1990-03       Impact factor: 22.682

2.  Ultrastructural abnormalities of myelinated fibres in the tibial nerve of streptozotocin-diabetic rats.

Authors:  P Dockery; A K Sharma
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

3.  Effect of bitter melon (Momordica charantia) fruit juice on the hepatic cytochrome P450-dependent monooxygenases and glutathione S-transferases in streptozotocin-induced diabetic rats.

Authors:  H Raza; I Ahmed; M S Lakhani; A K Sharma; D Pallot; W Montague
Journal:  Biochem Pharmacol       Date:  1996-11-22       Impact factor: 5.858

4.  Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids.

Authors:  C Karasu; M Dewhurst; E J Stevens; D R Tomlinson
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

5.  Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes.

Authors:  J Welihinda; E H Karunanayake; M H Sheriff; K S Jayasinghe
Journal:  J Ethnopharmacol       Date:  1986-09       Impact factor: 4.360

6.  The insulin-releasing activity of the tropical plant momordica charantia.

Authors:  J Welihinda; G Arvidson; E Gylfe; B Hellman; E Karlsson
Journal:  Acta Biol Med Ger       Date:  1982

7.  Peripheral nerve abnormalities in the diabetic mutant mouse.

Authors:  A K Sharma; P K Thomas; G Gabriel; C Stolinski; P Dockery; G W Hollins
Journal:  Diabetes       Date:  1983-12       Impact factor: 9.461

8.  Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve.

Authors:  K K Nickander; J D Schmelzer; D A Rohwer; P A Low
Journal:  J Neurol Sci       Date:  1994-10       Impact factor: 3.181

9.  Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.

Authors:  H S Hundal; T Ramlal; R Reyes; L A Leiter; A Klip
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

10.  Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats.

Authors:  P K Thomas; D W Wright; E Tzebelikos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-09       Impact factor: 10.154

View more
  23 in total

1.  Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice.

Authors:  Zhong Q Wang; Xian H Zhang; Yongmei Yu; Alexander Poulev; David Ribnicky; Z Elizabeth Floyd; William T Cefalu
Journal:  J Nutr Biochem       Date:  2011-01-28       Impact factor: 6.048

2.  Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats.

Authors:  A K Shetty; G Suresh Kumar; K Sambaiah; P V Salimath
Journal:  Plant Foods Hum Nutr       Date:  2005-09       Impact factor: 3.921

Review 3.  Antidiabetic plant-derived nutraceuticals: a critical review.

Authors:  Jayapal Naveen; Vallikannan Baskaran
Journal:  Eur J Nutr       Date:  2017-10-11       Impact factor: 5.614

4.  Evaluation of Protein Kinase Cβ and PPARγ Activity in Diabetic Rats Supplemented with Momordica charantia.

Authors:  Swetha Chandru; Prashant Vishwanath; Devananda Devegowda; Suresha Nagaraja Ramasamudra; Akila Prashant; Basavanagowdappa Hathur
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 5.  Traditional chinese medicine in treatment of metabolic syndrome.

Authors:  Jun Yin; Hanjie Zhang; Jianping Ye
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-06       Impact factor: 2.895

6.  Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions.

Authors:  Jaipaul Singh; Emmanuel Cumming; Gunasekar Manoharan; Huba Kalasz; Ernest Adeghate
Journal:  Open Med Chem J       Date:  2011-09-09

7.  Medicinal chemistry of novel anti-diabetic drugs.

Authors:  Ernest Adeghate
Journal:  Open Med Chem J       Date:  2011-09-09

8.  Binding Energy calculation of GSK-3 protein of Human against some anti-diabetic compounds of Momordica charantia linn (Bitter melon).

Authors:  Ridip Hazarika; Pratap Parida; Bijoy Neog; Raj Narain Singh Yadav
Journal:  Bioinformation       Date:  2012-03-31

9.  Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Authors:  Rooh Ullah Khan; Mohammad Bashir
Journal:  Nutr J       Date:  2015-01-26       Impact factor: 3.271

10.  Novel tissue-specific mechanism of regulation of angiogenesis and cancer growth in response to hyperglycemia.

Authors:  Sanghamitra Bhattacharyya; Kristina Sul; Irene Krukovets; Carla Nestor; Jianbo Li; Olga Stenina Adognravi
Journal:  J Am Heart Assoc       Date:  2012-12-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.